
|Videos|April 7, 2021
Opioid-free ureteroscopy initiatives appear to be reducing new-persistent opioid use
Author(s)Urology Times staff
“This paper shows that our efforts to reduce… opioid exposure in the postoperative setting is reducing new persistent opioid use,” says Matthew S. Lee, MD.
Advertisement
In this video, Matthew S. Lee, MD, discusses the recent Urology paper, “Opioid Free Ureteroscopy: what is the true failure rate?” for which he served as a study author. Lee was an endourology fellow at Indiana University at the time of the study and is currently a clinical instructor at Northwestern University Feinberg School of Medicine.
Newsletter
Stay current with the latest urology news and practice-changing insights — sign up now for the essential updates every urologist needs.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Urology Times
1
Mohit Khera, MD, recaps key takeaways from FDA panel on TRT for men
2
Experts urge FDA to revisit labeling for testosterone replacement therapy in men
3
FDA approves niraparib plus abiraterone acetate with prednisone for BRCA2+ mCSPC
4
FDA approves zoliflodacin for uncomplicated urogenital gonorrhea
5


















